Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001312 |
---|---|
Receipt number | R000001593 |
Scientific Title | Safety and efficacy of Alternating mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab every 4cycles as First line Therapy in Advanced colorectal Cancer |
Date of disclosure of the study information | 2008/08/12 |
Last modified on | 2017/01/13 13:37:26 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/08/12 20:01:10 | ||
2 | Update | 2009/09/15 19:52:10 | Recruitment status |
|
3 | Update | 2009/09/17 09:22:20 | UMIN ID1 |
|
4 | Update | 2009/10/28 12:41:01 | UMIN ID2 |
|
5 | Update | 2009/11/20 17:37:10 | Organization Organization Organization1 Institutions |
|
6 | Update | 2013/11/20 10:16:33 | Publication of results Results |
|
7 | Update | 2014/03/12 09:27:58 | TEL Last name of contact person Last name of contact person Address Address Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. Email1 |
|
8 | Update | 2015/05/22 07:55:25 | Email |
|
9 | Update | 2015/08/17 09:04:32 | Recruitment status Publication of results URL related to results and publications |
|
10 | Update | 2016/02/24 19:04:47 | Acronym Acronym |
|
11 | Update | 2017/01/13 13:18:56 | Name of primary person or sponsor Organization |
|
12 | Update | 2017/01/13 13:21:14 | Recruitment status Results |
|
13 | Update | 2017/01/13 13:37:26 | Public title |